Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Section 1: Insulin Release: Some Molecular Requisites

Sulfonylurea-Mediated Stimulation of Insulin Exocytosis via an ATP-Sensitive K+ Channel–Independent Action

  1. Erik Renström1,
  2. Sebastian Barg1,
  3. Frank Thévenod2 and
  4. Patrik Rorsman1
  1. 1Department of Molecular and Cellular Physiology, Institute of Physiology, Lund University, Lund, Sweden
  2. 2F.T. School of Biological Sciences, University of Manchester, Manchester, U.K.
    Diabetes 2002 Feb; 51(suppl 1): S33-S36. https://doi.org/10.2337/diabetes.51.2007.S33
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • FIG. 1.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 1.

      Photoaffinity labeling by [3H]-glibenclamide in the granule membrane fraction (GR; black curve) and plasma membrane fraction (PM; gray curve) of normal mouse islets. In the granule membrane fraction, a 65-kd protein is labeled, whereas in the plasma membrane fraction, a 140-kd protein with the expected molecular weight (Mr) for SUR-1 was detected. Radioactivity is plotted as fraction of peak radioactivity (599 cpm for PM and 1,109 cpm for GR). Granule protein (60 μg) and plasma membrane protein (73 μg) were equilibrated with 100 nmol/l [3H]-glibenclamide for 1 h and ultraviolet irradiated (3 min, 312 nm). Membrane protein from granule or plasma membrane fractions were separated by SDS-PAGE on 7.5% acrylamide gels, and radioactivity measured in a liquid scintillation counter. Using a low concentration of [3H]-glibenclamide (20 nmol/l), the granular 65-kd sulfonylurea receptor was inconsistently labeled, suggesting that it has a lower affinity than that of SUR-1. These experiments were performed using methods described in Braun et al. (19).

    • FIG. 2.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 2.

      A: Deprotonation of the granule interior estimated as the relative decrease (in percentage terms) of the initial LysoSensor-fluorescence intensity [(F0-F)/F0] after establishment of the standard whole-cell configuration. A standard Ca2+- and ATP-containing intracellular solution was used and supplemented with carbonyl cyanide m-chlorophenylhydrazone (CCCP) (ctrl; black, n = 14); ADP and CCCP (ADP; gray, n = 9); tolbutamide, ADP, and CCCP (tolb; gray, n = 10); diazoxide and CCCP (dz; black, n = 7); 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS) and CCCP (DIDS; black, n = 5); and anti-ClC-3, a functional antibody directed against the ClC-3 channel, and CCCP (anti-ClC-3; gray, n = 9). The arrow indicates the establishment of the standard whole-cell configuration. B: Average decrease (percentage of initial) in Lysosensor fluorescence after 60 s recording [(F0-F)/F0]. Data are means ± SE. Statistical significances were evaluated comparing the responses in the respective groups with the responses obtained with the control solution including CCCP. C: Increases in cell capacitance (ΔC) under control conditions (ctrl; black, n = 26), after addition of Mg-ADP (ADP; gray, n = 12), tolbutamide and Mg-ADP (tolb; gray, n = 12), diazoxide (dz; black, n = 19), or DIDS (black, n = 8). D: Average rate of changes in cell capacitance (ΔC/Δt) ± SE. **P < 0.01; ***P < 0.001. Data are modified from Barg et al. (14), where the methodology is described in detail.

    • FIG. 3.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 3.

      Model for the sulfonylurea-mediated stimulation of Ca2+-dependent insulin secretion. Sulfonylurea binding to a 65-kd receptor in the granule membrane (g-SUR) activates granular ClC-3 Cl− channels (ClC-3). The ClC-3 channels act in concert with the v-type H+-ATPase in the granule membrane to promote acidification of the granule interior, which is essential for the insulin granule to gain release competence. The exact nature of the interaction between g-SUR and the ClC-3 channel remains to be established. This putative g-SUR/ClC-3 channel complex is, however, under metabolic control and is activated when the ATP/ADP ratio is high. By analogy to the KATP channel, it seems likely that the inhibitory actions of ADP and diazoxide are mediated via g-SUR, whereas 4,4′-diisothiocyanostilbene-2,2′-disulfonic acid (DIDS) acts directly on the ClC-3 channel. The sulfonylurea-mediated stimulation of granule acidification, and in turn exocytosis, then result from perturbation of the ADP-mediated actions.

    PreviousNext
    Back to top

    In this Issue

    February 2002, 51(suppl 1)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Sulfonylurea-Mediated Stimulation of Insulin Exocytosis via an ATP-Sensitive K+ Channel–Independent Action
    (Your Name) has forwarded a page to you from Diabetes
    (Your Name) thought you would like to see this page from the Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Sulfonylurea-Mediated Stimulation of Insulin Exocytosis via an ATP-Sensitive K+ Channel–Independent Action
    Erik Renström, Sebastian Barg, Frank Thévenod, Patrik Rorsman
    Diabetes Feb 2002, 51 (suppl 1) S33-S36; DOI: 10.2337/diabetes.51.2007.S33

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Sulfonylurea-Mediated Stimulation of Insulin Exocytosis via an ATP-Sensitive K+ Channel–Independent Action
    Erik Renström, Sebastian Barg, Frank Thévenod, Patrik Rorsman
    Diabetes Feb 2002, 51 (suppl 1) S33-S36; DOI: 10.2337/diabetes.51.2007.S33
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • ATP-dependent priming in the β-cell.
      • SU-mediated effects on granule pH.
      • Model for the KATP-independent actions of sulfonylureas.
      • Acknowledgments
      • Footnotes
      • REFERENCES
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Two-Photon Excitation Imaging of Pancreatic Islets With Various Fluorescent Probes
    • Triggering of Insulin Release by a Combination of cAMP Signal and Nutrients
    Show more Section 1: Insulin Release: Some Molecular Requisites

    Similar Articles

    Navigate

    • Current Issue
    • Online Ahead of Print
    • Scientific Sessions Abstracts
    • Collections
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.